J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Slides:

Advertisements

Similar presentations

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Advertisements

Robert A. Guyton, MD The Annals of Thoracic Surgery

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with.

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Robert A. Guyton, MD The Annals of Thoracic Surgery

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Standardizing definitions for hybrid coronary revascularization

Elizabeth L. Nichols, MS, Jock N. McCullough, MD, Cathy S

Fred H. Edwards, MD, David M. Shahian, MD, Maria V

Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery Itzhak Herz, MD, Yaron Moshkovitz, MD,

Peter K. Smith, MD, Michel Carrier, MD, John C

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi.

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

Peter K. Smith, MD The Annals of Thoracic Surgery

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H

Off-Pump Versus On-Pump Coronary Revascularization: Meta-Analysis of Mid- and Long-Term Outcomes Umar A.R. Chaudhry, MBBS, Leanne Harling, MRCS, Christopher.

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies J. James Edelman,

Long-Term Outcomes After Transmyocardial Revascularization

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Long-Term Mortality of Coronary Artery Bypass Graft Surgery and Stenting With Drug- Eluting Stents Chuntao Wu, MD, PhD, Fabian T. Camacho, MS, Songyang.

Impact of Extracardiac Vascular Disease on Vein Graft Failure and Outcomes After Coronary Artery Bypass Surgery Ralf E. Harskamp, MD, John H. Alexander,

Coronary Revascularization in Patients With Liver Cirrhosis

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass for the Treatment of Left Main Coronary Stenosis Michael E. Halkos, MD, S. Tanveer.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Improved Outcomes of Total Arterial Myocardial Revascularization in Elderly Patients at Long-Term Follow-Up: A Propensity-Matched Analysis Gianluigi.

Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,

Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L

Minimally Invasive Direct Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Stenosis:

Alexander Iribarne, MD, MS, Anthony W. DiScipio, MD, Jock N

Coronary Artery Bypass Grafting After Percutaneous Intervention Has Higher Early Mortality: A Meta-Analysis Salah E. Altarabsheh, MD, Salil V. Deo, MS,

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Meta-Analysis of Medium and Long-Term Efficacy of Loading Statins After Coronary Artery Bypass Grafting Cheng Bin, MM, Mu Junsheng, MD, Zhang Jianqun,

Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

A. Laurie W. Shroyer, PhD, MSHA, Jacquelyn A. Quin, MD, MPH, Todd H

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease Noam Fink, MD, Eugenia Nikolsky, MD, Abid Assali, MD,

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

W. Brent Keeling, MD, Jose Binongo, PhD, Michael E

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Impact of Cardiothoracic Resident Turnover on Mortality After Cardiac Surgery: A Dynamic Human Factor Jeffrey H. Shuhaiber, MD, Kimberley Goldsmith,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Ravi K. Ghanta, MD, Prem S. Shekar, MD, Siobhan McGurk, BS, Donna M

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Revascularization in severe ventricular dysfunction (15% ≤ LVEF ≤ 30%): a comparison of bypass grafting and percutaneous intervention Koichi Toda, MD,

Previous Percutaneous Coronary Interventions Increase Mortality and Morbidity After Coronary Surgery Vito Mannacio, MD, Luigi Di Tommaso, MD, Vincenzo.

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K. Shaw, MS, Karen P. Alexander, MD, E. Magnus Ohman, MD, Manesh R. Patel, MD, Peter K. Smith, MD, Sunil V. Rao, MD The Annals of Thoracic Surgery Volume 104, Issue 1, Pages 107-115 (July 2017) DOI: 10.1016/j.athoracsur.2016.10.053 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Acquisition of study population. (Cath = catheterization; PCI = percutaneous coronary intervention; STEMI = ST-segment elevation myocardial infarction.) The Annals of Thoracic Surgery 2017 104, 107-115DOI: (10.1016/j.athoracsur.2016.10.053) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Annual distribution of therapeutic interventions: coronary artery bypass graft surgery (blue); percutaneous coronary intervention bare-metal stent (red); and percutaneous coronary intervention drug-eluting stent (green). (BMS = bare-metal stents; CABG = coronary artery bypass graft surgery; DES = drug-eluting stents; PCI = percutaneous coronary intervention.) The Annals of Thoracic Surgery 2017 104, 107-115DOI: (10.1016/j.athoracsur.2016.10.053) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier analysis for the composite outcome of death, myocardial infarction, and revascularization. Coronary artery bypass graft surgery (CABG [blue line]) was associated with significantly less risk for the primary outcome compared with percutaneous coronary intervention (PCI) with bare-metal stents (BMS [red line]) and drug-eluting stents (DES [green line]). (CI = confidence interval; vs. = versus.) The Annals of Thoracic Surgery 2017 104, 107-115DOI: (10.1016/j.athoracsur.2016.10.053) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Kaplan-Meier analysis for all-cause mortality. Coronary artery bypass graft surgery (CABG [blue line]) and percutaneous coronary intervention (PCI) with drug-eluting stents (DES [green line]) were associated with significantly less risk of all-cause mortality compared with PCI with bare-metal stents (BMS [red line]. (CI = confidence interval; vs. = versus.) The Annals of Thoracic Surgery 2017 104, 107-115DOI: (10.1016/j.athoracsur.2016.10.053) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions